Advertisement
New Zealand markets closed
  • NZX 50

    12,845.64
    +91.06 (+0.71%)
     
  • NZD/USD

    0.6102
    +0.0006 (+0.10%)
     
  • NZD/EUR

    0.5578
    +0.0010 (+0.18%)
     
  • ALL ORDS

    8,491.50
    -7.20 (-0.08%)
     
  • ASX 200

    8,214.50
    -8.50 (-0.10%)
     
  • OIL

    75.67
    -0.18 (-0.24%)
     
  • GOLD

    2,660.80
    +21.50 (+0.81%)
     
  • NASDAQ

    20,241.76
    -27.10 (-0.13%)
     
  • FTSE

    8,237.73
    -6.01 (-0.07%)
     
  • Dow Jones

    42,454.12
    -57.88 (-0.14%)
     
  • DAX

    19,210.90
    -44.03 (-0.23%)
     
  • Hang Seng

    21,251.98
    +614.74 (+2.98%)
     
  • NIKKEI 225

    39,566.71
    +185.82 (+0.47%)
     
  • NZD/JPY

    90.6690
    +0.1760 (+0.19%)
     

The Alzheimer's Drug Market Is Heating Up. Should You Buy the Leading Contenders' Stocks?

The Alzheimer's Drug Market Is Heating Up. Should You Buy the Leading Contenders' Stocks?

It's a no-brainer to invest in businesses that are making headway in the growth markets of the future. In biopharma, therapies to treat or prevent Alzheimer's disease constitute one such growth market. Let's survey the competitive landscape as it is today, and think through how it's likely to develop.